Honeywell Acquires QMS Provider Sparta Systems

Dec. 23, 2020
Honeywell expands life sciences and software capabilities through acquisition of Sparta Systems.

Honeywell announces it has agreed to acquire privately held Sparta Systems for $1.3 billion in an all-cash transaction from New Mountain Capital. Sparta Systems is a provider of enterprise quality management software (QMS), including a next-generation SaaS platform, for the life sciences industry.

Honeywell says it will leverage its global presence, Honeywell Forge and Sparta's expertise to introduce new, integrated offerings, including QMS offerings, for life sciences and adjacent industries. Honeywell's customers will benefit from advanced digital QMS offerings to help them proactively achieve better quality, which results in improved new therapies, faster time to market, better business and patient outcomes and effective regulatory compliance, according to the company.

Honeywell's portfolio includes advanced automation and process controls for consistency and oversight of both continuous and batch processing; data capture and recording offerings that simplify and safeguard compliance; and technologies that help maintain auditability, optimize production and speed time to market while ensuring quality and repeatability. Honeywell's Fast Track Automation helps life science manufacturers expedite development and production of vital vaccines and medical therapies, according to the company.

Sparta Systems is headquartered in Hamilton, N.J., and has approximately 250 employees globally. Sparta serves more than 400 customers, including 42 of the world's top 50 pharma companies and 33 of the top 50 medical device companies, according to Honeywell.

Honeywell will continue to enhance TrackWise Digital QMS by adding AI and machine learning capabilities that augment human decision making. Honeywell will also add new IoT-enabled connectivity between quality and operational data to detect manufacturing anomalies and triage quality events in near real time. These continuing innovations will help customers proactively address quality to improve patient safety and effective regulatory compliance, according to Honeywell.

The acquisition is expected to close by the end of the first quarter of 2021 and is subject to certain regulatory approvals and other customary closing conditions. There is no change to Honeywell's 2020 financial outlook as a result of the acquisition.

For more information, visit: www.honeywell.com